Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Seoul National University Bundang Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Hoil Yoon, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT01580748
First received: April 18, 2012
Last updated: NA
Last verified: April 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)